ArticleJournal for immunotherapy of cancer2024

rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors.

Minji Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.